Cargando…

Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

Extracellular vesicles (EVs), comprising exosomes, microvesicles, and apoptotic bodies, are released by all cells into the extracellular matrix and body fluids, where they play important roles in intercellular communication and matrix remodeling in various pathological conditions. Malignant pleural...

Descripción completa

Detalles Bibliográficos
Autores principales: Javadi, Joman, Görgens, André, Vanky, Hanna, Gupta, Dhanu, Hjerpe, Anders, EL-Andaloussi, Samir, Hagey, Daniel, Dobra, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615485/
https://www.ncbi.nlm.nih.gov/pubmed/34827604
http://dx.doi.org/10.3390/biom11111606
_version_ 1784604116100579328
author Javadi, Joman
Görgens, André
Vanky, Hanna
Gupta, Dhanu
Hjerpe, Anders
EL-Andaloussi, Samir
Hagey, Daniel
Dobra, Katalin
author_facet Javadi, Joman
Görgens, André
Vanky, Hanna
Gupta, Dhanu
Hjerpe, Anders
EL-Andaloussi, Samir
Hagey, Daniel
Dobra, Katalin
author_sort Javadi, Joman
collection PubMed
description Extracellular vesicles (EVs), comprising exosomes, microvesicles, and apoptotic bodies, are released by all cells into the extracellular matrix and body fluids, where they play important roles in intercellular communication and matrix remodeling in various pathological conditions. Malignant pleural mesothelioma (MPM) is a primary tumor of mesothelial origin, predominantly related to asbestos exposure. The detection of MPM at an early stage and distinguishing it from benign conditions and metastatic adenocarcinomas (AD) is sometimes challenging. Pleural effusion is often the first available biological material and an ideal source for characterizing diagnostic and prognostic factors. Specific proteins have previously been identified as diagnostic markers in effusion, but it is not currently known whether these are associated with vesicles or released in soluble form. Here, we study and characterize tumor heterogeneity and extracellular vesicle diversity in pleural effusion as diagnostic or prognostic markers for MPM. We analyzed extracellular vesicles and soluble proteins from 27 pleural effusions, which were collected and processed at the department of pathology and cytology at Karolinska University Hospital, representing three different patient groups, MPM (n = 9), benign (n = 6), and AD (n = 12). The vesicles were fractionated into apoptotic bodies, microvesicles, and exosomes by differential centrifugation and characterized by nanoparticle tracking analysis and Western blotting. Multiplex bead-based flow cytometry analysis showed that exosomal markers were expressed differently on EVs present in different fractions. Further characterization of exosomes by a multiplex immunoassay (Luminex) showed that all soluble proteins studied were also present in exosomes, though the ratio of protein concentration present in supernatant versus exosomes varied. The proportion of Angiopoietin-1 present in exosomes was generally higher in benign compared to malignant samples. The corresponding ratios of Mesothelin, Galectin-1, Osteopontin, and VEGF were higher in MPM effusions compared to those in the benign group. These findings demonstrate that relevant diagnostic markers can be recovered from exosomes.
format Online
Article
Text
id pubmed-8615485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86154852021-11-26 Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion Javadi, Joman Görgens, André Vanky, Hanna Gupta, Dhanu Hjerpe, Anders EL-Andaloussi, Samir Hagey, Daniel Dobra, Katalin Biomolecules Article Extracellular vesicles (EVs), comprising exosomes, microvesicles, and apoptotic bodies, are released by all cells into the extracellular matrix and body fluids, where they play important roles in intercellular communication and matrix remodeling in various pathological conditions. Malignant pleural mesothelioma (MPM) is a primary tumor of mesothelial origin, predominantly related to asbestos exposure. The detection of MPM at an early stage and distinguishing it from benign conditions and metastatic adenocarcinomas (AD) is sometimes challenging. Pleural effusion is often the first available biological material and an ideal source for characterizing diagnostic and prognostic factors. Specific proteins have previously been identified as diagnostic markers in effusion, but it is not currently known whether these are associated with vesicles or released in soluble form. Here, we study and characterize tumor heterogeneity and extracellular vesicle diversity in pleural effusion as diagnostic or prognostic markers for MPM. We analyzed extracellular vesicles and soluble proteins from 27 pleural effusions, which were collected and processed at the department of pathology and cytology at Karolinska University Hospital, representing three different patient groups, MPM (n = 9), benign (n = 6), and AD (n = 12). The vesicles were fractionated into apoptotic bodies, microvesicles, and exosomes by differential centrifugation and characterized by nanoparticle tracking analysis and Western blotting. Multiplex bead-based flow cytometry analysis showed that exosomal markers were expressed differently on EVs present in different fractions. Further characterization of exosomes by a multiplex immunoassay (Luminex) showed that all soluble proteins studied were also present in exosomes, though the ratio of protein concentration present in supernatant versus exosomes varied. The proportion of Angiopoietin-1 present in exosomes was generally higher in benign compared to malignant samples. The corresponding ratios of Mesothelin, Galectin-1, Osteopontin, and VEGF were higher in MPM effusions compared to those in the benign group. These findings demonstrate that relevant diagnostic markers can be recovered from exosomes. MDPI 2021-10-29 /pmc/articles/PMC8615485/ /pubmed/34827604 http://dx.doi.org/10.3390/biom11111606 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Javadi, Joman
Görgens, André
Vanky, Hanna
Gupta, Dhanu
Hjerpe, Anders
EL-Andaloussi, Samir
Hagey, Daniel
Dobra, Katalin
Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title_full Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title_fullStr Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title_full_unstemmed Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title_short Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
title_sort diagnostic and prognostic utility of the extracellular vesicles subpopulations present in pleural effusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615485/
https://www.ncbi.nlm.nih.gov/pubmed/34827604
http://dx.doi.org/10.3390/biom11111606
work_keys_str_mv AT javadijoman diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT gorgensandre diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT vankyhanna diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT guptadhanu diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT hjerpeanders diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT elandaloussisamir diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT hageydaniel diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion
AT dobrakatalin diagnosticandprognosticutilityoftheextracellularvesiclessubpopulationspresentinpleuraleffusion